Retracted: Treatment outcome of multi-drug resistant tuberculosis patients on second line anti-tuberculosis dugs at tertiary care hospital at Himachal Pradesh, India
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20203387Keywords:
Second line antitubercular drugs, Treatment outcome, MDR-TBAbstract
The article "Treatment outcome of multi-drug resistant tuberculosis patients on second line anti-tuberculosis dugs at tertiary care hospital a Himachal Pradesh, India" is retracted by the Editor-in-Chief, due to violation of the policies and practices of International Journal of Community Medicine and Public Health. The article is retracted due to dispute in authorship.
References
Central TB Division, Directorate General of Health services, Ministry of Health and Family Welfare, Government of India. Guidelines on Programmatic Management of Drug Resistant TB (PMDT) Guideline 2012. New Delhi.
Central TB Division (CTD), Directorate General of Health services, Ministry of Health and Family Welfare, Government of India, Programmatic Management of Drug Resistant TB (PMDT) Guidelines 2017. New Delhi.
WHO. Fact sheet: Multidrug-resistant–TB updates 2017. Available at http:// www.who.int/ tb/challenges/mdr. Accessed on 17 September 2018.
Wahab F, Ashraf S, Khan N, Anwar R, Afridi MZ. Risk factors for multi-drug resistant tuberculosis in patients at tertiary care hospital. J College Phys Surg. 2009;9(3):162-4.
Jain K, Desai M, Solanki R, Dikshit RK. Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis. J Pharmacol Pharmacother. 2014;5(2):145-9.
Central TB Division, Directorate General of Health services, Ministry of Health and Family Welfare, Government of India. RNTCP annual status report TB India. 2014:175-177.
Patel SV, Nimavat KB, Patel AB, Mehta KG, Shringarpure K, Shukla LK. Sputum smear and culture conversion in multidrug resistance tuberculosis patients in seven districts of central Gujarat, India: a longitudinal study. Indian J Commu Med. 2018;43:117-9.
World Health Organization. Treatment of Tuberculosis: Guidelines for National Programmes. Geneva: World Health Organization; 2003.
World Health Organisation. Guidelines for establishing DOTS Plus Pilot Projects for the management of multidrug-resistant tuberculosis (MDR-TB). 2000.
